Status | Study |
Completed |
Study Name: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis Condition: Cytomegalovirus Epstein-Barr Virus Infections Date: 2010-11-21 |
Active, not recruiting |
Study Name: Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy Condition: Nasopharyngeal Cancer Epstein-Barr Virus Infections Date: 2010-03-26 Interventions: Biological: Recombinant Epstein-Barr Virus (EBV) Vaccine |
Completed |
Study Name: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) Condition: Adenovirus Infection Epstein-Barr Virus Infections Date: 2010-02-16 Interventions: Biological: Multi-virus Specific T cells Subjects will rec |
Active, not recruiting |
Study Name: Bortezomib Plus Rituximab for EBV+ PTLD Condition: Post-transplant Lymphoproliferative Disease Solid Organ Transplant Date: 2010-01-26 Interventions: Drug: bortezomib Given intrave |
Completed |
Study Name: EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients Condition: Epstein-Barr Virus Infections Date: 2009-08-20 |
Completed |
Study Name: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) Condition: Adenovirus Infection EBV Infection Date: 2008-06-20 Interventions: Biological: Trivirus Specific CTLs for EBV, CMV and Adenovirus Infection |
Completed |
Study Name: Surveillance Study of Viral Infections Following Lung Transplantation Condition: Lung Transplantation Bronchiolitis Obliterans Date: 2008-06-17 |
Completed |
Study Name: Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection Condition: Infectious Mononucleosis Date: 2007-12-14 Interventions: Drug: Valomaciclovir 4 grams o |
Completed |
Study Name: EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) Condition: Nasopharyngeal Cancer EBV Infections Date: 2004-03-01 Interventions: Biological: EBV specific CTL Infusion |
Completed |
Study Name: Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations Condition: Epstein-Barr Virus Infections Date: 2003-10-07 |